Brüningk, Sarah C.
Peacock, Jeffrey
Whelan, Christopher J.
Brady-Nicholls, Renee
Yu, Hsiang-Hsuan M.
Sahebjam, Solmaz
Enderling, Heiko
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (190647)
National Institutes of Health (U54CA143970, R21CA234787)
Article History
Received: 22 December 2020
Accepted: 20 September 2021
First Online: 12 October 2021
Change Date: 15 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-08620-3
Competing interests
: SS receives research support from Merck, Bristol Myers Squibb, and Brooklyn ImmunoTherapeutics and acts as advisory board member for Merck, and Boehringer Ingelheim. HY is on the advisory board of AbbVie and Novocure and is a member of the speaker bureau of BrainLab. HY also receives a honorarium from UpToDate. The remaining authors declare that they have no competing interests.